StockGlow

Eli Lilly and Company (LLY.DE)

Makes medicines for diabetes, cancer, and autoimmune diseases.

1,075.80+0.01%Healthcare
Compare LLY.DE with
StockGlow Score
96
Bullish
BearishBullish
1 year ago+64.2%

The outlook

Eli Lilly stock is trading near its 52-week highs, well above both its 50- and 200-day moving averages. The trailing P/E of 43.4 reflects a premium valuation. Analyst sentiment appears strongly positive based on current market positioning.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$959.34B
52-wk high
1,090.80
52-wk low
535.80
50-day avg
998.33
200-day avg
887.77
Trailing P/E
43.4

Similar stocks

JNJ.DEJohnson & Johnson$235.65-0.30%LLY.FEli Lilly and Company$1,070.20-0.35%6MK.DEMerck & Co., Inc.$115.74-0.07%M4I.DEMastercard Incorporated$497.90+1.08%NOV.DENovo Nordisk A/S$45.26+1.38%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy